Showing results (401-410 of 609) with videos related to

Sort By:
Pageof 61
Urology|December 11, 2007
Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA eraNaresh V Desireddi, Kimberly A Roehl, Stacy Loeb, et al.
Sleep Medicine|April 30, 2022
Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer careRebecca Robbins, Renee Cole, Chidera Ejikeme, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 4, 2015
Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?Hendrik Borgmann, Jan-Henning Wölm, Stefan Vallo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 5, 2026
Balancing Cure and Quality of Life: Navigating Functional Outcomes in Localized Prostate CancerAbby L Grier, Erik Briers, Randie E White, et al.
Patient Education and Counseling|September 10, 2017
Informational needs during active surveillance for prostate cancer: A qualitative studyStacy Loeb, Caitlin Curnyn, Angela Fagerlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 yearsStephen J Freedland, William B Isaacs, Leslie A Mangold, et al.
Urology|March 8, 2013
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillanceYun-Sok Ha, Amirali Salmasi, Michael Karellas, et al.
Urology|June 19, 2007
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?John C Mavropoulos, Alan W Partin, Christopher L Amling, et al.
The Journal of Urology|December 14, 2007
CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancerPatrick J Bastian, Ganesh S Palapattu, Srinivasan Yegnasubramanian, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
Pageof 61